Arcus Biosciences, Inc.RCUSNYSE
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+2.5%
5Y CAGR+5.1%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+2.5%/yr
vs +30.5%/yr prior
5Y CAGR
+5.1%/yr
Consistent
Acceleration
-28.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $222.00M | +48.0% |
| 2024 | $150.00M | +18.1% |
| 2023 | $127.00M | -38.3% |
| 2022 | $206.00M | +39.3% |
| 2021 | $147.91M | -14.7% |
| 2020 | $173.41M | +199.3% |
| 2019 | $57.94M | -18.5% |
| 2018 | $71.06M | -27.8% |
| 2017 | $98.43M | +51.1% |
| 2016 | $65.16M | - |